Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

Agriculture Secretary Tom Vilsack to Discuss Access and Equality at BIO Digital

June 13, 2021

With only one day until BIO Digital, the Biotechnology Innovation Organization (BIO) continues to add to its impressive line-up of featured speakers. Today, BIO announced that U.S. Agriculture Secretary Tom Vilsack will join BIO President and CEO Dr…

BIO Elects Paul Hastings as New Board Chair

June 11, 2021

New Officers Join BIO’s Governing Boards

BIO Takes on Health Equity in Clinical Trials

June 10, 2021

First-ever BIO Clinical Trial Diversity Summit will engage stakeholders to build a sustainable and equitable clinical development ecosystem

BIO Cheers Biden Announcement to Share 20 Million Doses of Vaccines with Developing Nations

May 18, 2021

"The White House’s decision to send Covid-19 vaccines to countries in need is an important step to ensuring people around the globe have access to lifesaving shots and ending this global pandemic. “As part of BIO’s recently-proposed Global “SHARE”…

BIO Extends Agreement with Avantor

May 10, 2021

Today, the Biotechnology Innovation Organization (BIO) announced an extension through June 2029 to its established agreement with Avantor. Through this agreement, members across North America have access to a broad…

Support of "TRIPS" Waiver Sets Dangerous Precedent

May 5, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…

Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs

May 4, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…

BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH

May 3, 2021

Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders

BIO's Dr. Michelle McMurry-Heath Comments on Passage of Washington State's Clean Fuel Standard

April 26, 2021

BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement following the passage of a clean fuel standard bill (HB 1091) in Washington state. "With the passage of HB 1091, Washington state is showing once again that climate…

H.R. 3 To Handicap Future Medical Innovation, Destroy Hope for Vulnerable Patients

April 22, 2021

Following the re-introduction of the H.R. 3 drug pricing legislation, Rich Masters -- Chief Public Affairs and Advocacy Officer of the Biotechnology Innovation Organization (BIO) -- made the following remarks: "On behalf of BIO’s…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.